Coronavirus channel feed

Bay­er fires em­ploy­ee who was spot­ted break­ing quar­an­tine in Chi­na

6 years ago
China
Pharma

Covid-19 roundup: Trump back­tracks on NIH/CDC fund­ing, No­var­tis launch­es $20M fund, FDA and ICER can­cel­la­tions

6 years ago
R&D

As Covid-19 R&D goes in­to over­drive, nuts-and-bolts bio­phar­ma re­search is hit­ting the skids. How bad is it?

6 years ago
R&D

Con­tract man­u­fac­tur­er: FDA has halt­ed do­mes­tic phar­ma in­spec­tions

6 years ago
FDA+

UK takes tougher stance to com­bat coro­n­avirus, as pre­vi­ous ap­proach risks hun­dreds of thou­sands of lives — study

6 years ago

‘Pa­tient ze­ro’ in Ten­nessee talks about fear, anx­i­ety, hys­te­ria and count­less acts of kind­ness as the Bio­gen out­break spreads

6 years ago
People

Covid-19 roundup — Re­gen­eron zooms in on cock­tail; BioN­Tech shares sky­rock­et on quick Pfiz­er al­liance

6 years ago

‘It’s like the tor­toise and the hare’: A pan­dem­ic puts Sanofi’s $600M bet to the test

6 years ago
R&D
In Focus

Bio­gen staffer fled to Chi­na in search of emer­gency Covid-19 test­ing, care — and now faces crim­i­nal charges

6 years ago
People

EMA of­fers free sci­en­tif­ic ad­vice for Covid-19 de­vel­op­ers

6 years ago

'We're led by the sci­ence': UK's plan to de­lay coro­n­avirus peak and pur­sue herd im­mu­ni­ty trig­gers up­roar

6 years ago

BioN­Tech teams up with Fo­s­un Phar­ma to test Covid-19 mR­NA vac­cine in Chi­na — and scores $50M in­vest­ment

6 years ago
R&D

Covid-19 roundup: Re­gen­eron, Sanofi launch coro­n­avirus pro­gram; NIH staffer tests pos­i­tive for coro­n­avirus, Mod­er­na vac­cine tri­al starts

6 years ago
R&D

Trump ad­min­is­tra­tion tries to lure Ger­man coro­n­avirus vac­cine mak­er to US — re­ports

6 years ago
R&D

Bio­gen’s Covid-19 tal­ly breaks past the 100 mark, feed­ing the state to­tal as the con­ta­gion wreaks hav­oc

6 years ago

Biotech en­tre­pre­neurs Arie Bellde­grun and Cedric Fran­cois test pos­i­tive for Covid-19 — and here's why they want you to know

6 years ago
People

Eli Lil­ly teams with an­ti­body up­start Ab­Cellera in coro­n­avirus hunt

6 years ago
R&D

FDA of­fers Roche an emer­gency OK for coro­n­avirus test­ing tech — eas­ing a crit­i­cal log­jam

6 years ago
FDA+

Bio­gen out­break con­tin­ues to spur new coro­n­avirus cas­es in Mass­a­chu­setts as health of­fi­cials strug­gle to keep up with test­ing de­mands

6 years ago
R&D

As the coro­n­avirus pan­dem­ic con­tin­ues to rat­tle the world, bio­phar­ma braces for a few new shocks to the sys­tem

6 years ago

With WuXi and Al­ny­lam in tow, Vir en­lists NIH as it tests var­i­ous tools to fight the coro­n­avirus scourge

6 years ago
R&D

An­a­lysts start to sort out which bio­phar­ma com­pa­nies’ R&D plans are most threat­ened by a pan­dem­ic

6 years ago
R&D

Bio­gen out­break now tied to 70 cas­es of coro­n­avirus as state to­tal more than dou­bles in 1 day

6 years ago

Coro­n­avirus up­date: Eli Lil­ly staffer tests pos­i­tive, FDA post­pones in­spec­tions and AACR is can­celed as out­break roils bio­phar­ma

6 years ago
First page Previous page 565758596061 Next page Last page
A service from the Financial Times